Vitr is a biotechnology company that specializes in developing innovative solutions for drug discovery and development. The company focuses on leveraging advanced computational methods and machine learning to enhance the efficiency of biopharmaceutical research. Vitr aims to streamline the process of identifying and optimizing therapeutic candidates, ultimately accelerating the path to market for new treatments. Their platform integrates data from various sources to provide insights that support decision-making in the drug development process.